Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Frontiers in Cardiovascular Medicine|July 12, 2021
Circle the Cardiac Remodeling With circRNAsTiqun Yang, Tianxin Long, Tailai Du, et al.Frontiers in Cell and Developmental Biology|April 19, 2021
Inhibiting miR-22 Alleviates Cardiac Dysfunction by Regulating Sirt1 in Septic CardiomyopathyRunze Wang, Yuerong Xu, Wei Zhang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 7, 2021
The cardiac translational landscape reveals that micropeptides are new players involved in cardiomyocyte hypertrophyYouchen Yan, Rong Tang, Bin Li, et al.Hypertension (Dallas, Tex. : 1979)|November 19, 2019
Transcribed Ultraconserved Regions, Uc.323, Ameliorates Cardiac Hypertrophy by Regulating the Transcription of CPT1b (Carnitine Palmitoyl transferase 1b)Yu Sun, Wendong Fan, Ruicong Xue, et al.Cardiovascular Research|July 8, 2026
Long noncoding RNA CARDINAL cis-activates MYOCD expression by recruiting histone reader ZZZ3 in vascular smooth muscle cell phenotype alterationHuimin Zhou, Shaozhao Zhang, Xingfeng Xu, et al.Theranostics|November 8, 2019
Maf1 ameliorates cardiac hypertrophy by inhibiting RNA polymerase III through ERK1/2Yu Sun, Cong Chen, Ruicong Xue, et al.Frontiers in Cardiovascular Medicine|April 4, 2022
Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart FailureYouchen Yan, Tianxin Long, Qiao Su, et al.The Journal of Clinical Investigation|May 14, 2024
The long noncoding RNA CARDINAL attenuates cardiac hypertrophy by modulating protein translationXin He, Tiqun Yang, Yao Wei Lu, et al.Journal for Immunotherapy of Cancer|August 22, 2020
An immune evasion mechanism with IgG4 playing an essential role in cancer and implication for immunotherapyHui Wang, Qian Xu, Chanyuan Zhao, et al.Pageof 1